Marking a Milestone: The Modernized ClinicalTrials.gov Becomes the Singular Website Experience

Posted
Anna M. Fine, PharmD, MS, Acting Director, ClinicalTrials.gov

Guest post by Anna M. Fine, PharmD, MS, originally posted on the National Library of Medicine (NLM) blog, Musings from the Mezzanine.

On June 25, 2024, the modernized ClinicalTrials.gov will become the singular website experience. This major milestone is part of NLM’s multi-year ClinicalTrials.gov modernization effort, which has been guided by stakeholder engagement, input from the NLM Board of Regents Public Service Working Group, and a user-centered design approach.

Since 2019, we have provided updates on NLM’s progress in modernizing ClinicalTrials.gov, the world’s largest clinical trial and results registry. The modernization effort has focused on delivering an improved user experience on an updated platform that will accommodate growth and enhance efficiency. In March 2023, to provide users with time to transition, we announced that the classic ClinicalTrials.gov website will be retired in 2024.

Importantly, the retirement of the classic version of the website does not mark the end of this modernization. NLM will continue to enhance and update the modernized ClinicalTrials.gov and release additional features such as functionality to browse studies by topic and expert search capabilities. NLM also continues to work on modernizing the Protocol Registration and Results System (PRS), the clinical trial information submission and management portal for ClinicalTrials.gov. An enhanced results information submission process is coming soon, and PRS Beta will become the new primary registration website later this summer.

Feedback plays an important role in assessing the impact of this modernization effort, and we encourage users to share their comments. Please use the feedback button on the modernized website to ensure that we hear from you. For additional information about modernization-related events and resources, visit the ClinicalTrials.gov Modernization webpage.

2 Comments

Before submitting your comment, please review our blog comment policies.

Leave a Reply

Your email address will not be published. Required fields are marked *